Roche and ParAllele form diabetes research pact
This article was originally published in Clinica
Executive Summary
In a bid to develop new diagnostics and drugs for treating and managing type 2 diabetes, Roche and ParAllele BioScience have linked up to discover genes and genetic variations that contribute to the disease.